Clinical parameter | GAS5 | Chi-squared testP-value | |
---|---|---|---|
 | High- GAS5 group, no. of cases | Low-GAS5 group, no. of cases |  |
Age (years) | Â | Â | Â |
<50 | 21 | 25 | 0.338 |
>50 | 24 | 19 | Â |
Gender | Â | Â | 0.101 |
Male | 23 | 30 | Â |
Female | 22 | 14 | Â |
Location | Â | Â | 0.839 |
Distal | 17 | 19 | Â |
Middle | 18 | 17 | Â |
Proximal | 10 | 8 | Â |
Size | Â | Â | 0.008 |
>5Â cm | 16 | 28 | Â |
<5Â cm | 29 | 16 | Â |
Histologic differentiation | Â | Â | 0.376 |
Well | 3 | 3 | Â |
Moderately | 19 | 11 | Â |
Poorly | 19 | 24 | Â |
Undifferentiated | 4 | 6 | Â |
Invasion depth | Â | Â | <0.001 |
T1 | 16 | 5 | Â |
T2 | 18 | 8 | Â |
T3 | 6 | 17 | Â |
T4 | 5 | 14 | Â |
TNM Stage | Â | Â | 0.038 |
I | 11 | 4 | Â |
II | 20 | 14 | Â |
III | 13 | 22 | Â |
IV | 1 | 4 | Â |
Lymphatic metastasis | Â | Â | 0.072 |
Yes | 27 | 18 | Â |
No | 18 | 26 | Â |
Regional lymph nodes | Â | Â | <0.001 |
PN0 | 28 | 17 | Â |
PN1 | 12 | 4 | Â |
PN2 | 3 | 15 | Â |
PN3 | 2 | 8 | Â |
Distant metastasis | Â | Â | 0.056 |
Yes | 0 | 4 | Â |
No | 45 | 40 | Â |